Carl Zeiss Meditec Is Shaping the Future of Ophthalmology: Creating What's to Come.
(Thomson Reuters ONE) -
Carl Zeiss Meditec AG / Carl Zeiss Meditec Is Shaping the Future of Ophthalmology: Creating What's to Come. processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
The company's new booth and innovative products for ophthalmology will be
introduced at the 2010 ESCRS in Paris.
JENA - September 2, 2010.
Carl Zeiss Meditec is once again presenting its expanded offer of solutions for
cataract, refractive and retina applications. Under the theme - Creating what's
to come - the company is demonstrating how it would like to shape the future of
ophthalmology with its products and solutions.
The following will be on display at the 2010 ESCRS:
* ZEISS MICS Plattform - With the launch of the BLUEMIXS(TM) 180 injector for
preloaded MICS IOLs, and the largest range of MICS IOLs on the market, OVDs
and phaco technology, Carl Zeiss Meditec provides doctors with a total
integrated product platform for micro-incision surgery.
* The future of the ZEISS toric solution - building on the existing ZEISS
solution for the implantation of toric IOLs, the company is exhibiting the
next generation with which toric intraocular lenses (IOLs) can be implanted
and aligned as easily as standard IOLs.
* FORUM ready - All ophthalmic diagnostic instruments from Carl Zeiss shown at
the ESCRS can be combined into one system with FORUM. The necessary DICOM
interface is available as part of the "FORUM ready" offering. It allows
doctors to optimize their workflows and data management and enables better
data networking in the practice and the OR.
* VISULAS Trion VITE - The world's only three-color laser that can apply
multi-spot cascades and thus enable considerably gentler treatment of
patients with retinal diseases.
"'Creating what's to come' stands for our ambition to move forward with
innovations, create something new and shape the future of ophthalmology and
therefore medical progress. I am proud that we are able to once again exhibit
many new innovations and our extensive product portfolio at the ESCRS," states
Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG.
Carl Zeiss Meditec supplies its customers with a unique ZEISS MICS platform that
meets all the needs of micro-incision surgery.
The components of the ZEISS MICS platform at a glance:
* ZEISS MICS IOL portfolio - Carl Zeiss Meditec offers the largest range of
MICS IOLs on the market - the right IOL for any eye.
· VISALIS: phaco technology from Carl Zeiss - with the VISALIS phaco
technology as a component of the ZEISS MICS platform, Carl Zeiss provides
optimized phaco handpieces and MICS-suitable fluidics to enable the smallest
possible incision and good vacuum control.
* ZEISS OVDs - more than 25 years of experience in the development and
manufacture of unique OVDs coupled with outstanding quality standards. Carl
Zeiss offers a wide range of innovative OVDs - the right product for any
operation.
* BLUEMIXS(TM) 180 - introduced for the first time at the ESCRS, BLUEMIXS 180
is the first injector on the market for the largest range of preloaded MICS
IOLs from Carl Zeiss. Doctors benefit from the improved safety and
user-friendliness of the injector specially developed for MICS operations.
With an incision of just 1.8 mm, they are able to obtain the best results.
BLUEMIXS 180 guarantees the correct placement of the IOL and covers the
entire diopter range of ZEISS MICS IOLs.
Building on the existing ZEISS solution for the implantation of toric IOLs, the
company is exhibiting the future of the ZEISS toric solution: the optimization
and simplification of the workflow for the implantation of toric IOLs will be
demonstrated through the enhanced interaction of existing ZEISS products. For
example, at the push of a button it will be possible to calculate toric IOLs
without having to reenter the measured values and overlay the target axis in the
microscope.
Carl Zeiss has also prepared a special ESCRS offer for its FORUM ready
customers: ophthalmic diagnosis instruments will be delivered with a DICOM
interface. This will enable them to combine instruments into one system that
optimizes workflows and data management in the practice and the OR.
The new VISULAS Trion VITE laser optimally supplements the product line for
retina treatment. The world's only multi-wavelength laser that can apply
multi-spot cascades, it enables improved results, shorter treatment times and
increased treatment comfort.
Visitors to the ESCRS can learn more about the entire offering of products and
solutions from Carl Zeiss Meditec at Booth 215 in Hall Maillot. Congress
participants can also register for the ZEISS events during the ESCRS at
www.meditec.zeiss.com/escrs.
Contact:
Eva Sesselmann Patrick Kofler
Director Group Communications Director Investor Relations
Carl Zeiss Meditec AG Carl Zeiss Meditec AG
Göschwitzer Strasse 51-52 Göschwitzer Strasse 51-52
07745 Jena 07745 Jena
Telefon: +49 3641 220-331 Telefon: +49 3641 220-106
Telefax: +49 3641 220-332 Telefax: +49 3641 220-117
Email:press(at)meditec.zeiss.com Email:investors(at)meditec.zeiss.com
[HUG#1442263]
--- End of Message ---
Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany
WKN: 531370;ISIN: DE0005313704;Index:TecDAX,Prime All Share,TECH All Share;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Carl Zeiss Meditec AG via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 02.09.2010 - 11:01 Uhr
Sprache: Deutsch
News-ID 41120
Anzahl Zeichen: 0
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 214 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Carl Zeiss Meditec Is Shaping the Future of Ophthalmology: Creating What's to Come."
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
